NCT04927221View on ClinicalTrials.gov

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability of DC371739 Treatment in Hypercholesterolemic

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

December 21, 2021

Study Completion Date

December 21, 2021

Conditions

Hypercholesterolemia

Interventions

DRUG

DC371739 Tablets

Participants received one of 5 dose levels of DC371739 administered as single oral doses.

DRUG

Placebo

Placebo orally administered as comparison

Trial Locations (1)

Unknown

The First Hospital of Jilin University, Changchun

All Listed Sponsors

collaborator

The First Hospital of Jilin University

OTHER

lead

Guangzhou JOYO Pharma Co., Ltd

INDUSTRY

NCT04927221 - Multiple Ascending Dose Study to Evaluate the Safety, Tolerability of DC371739 Treatment in Hypercholesterolemic | Biotech Hunter | Biotech Hunter